Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mahmoud Salama, Vladimir Isachenko, Evgenia Isachenko, Gohar Rahimi & Peter Mallmann. (2017) Advances in fertility preservation of female patients with hematological malignancies. Expert Review of Hematology 10:11, pages 951-960.
Read now
Read now
Alicia Tosoni, Damiano Balestrini & Alba A. Brandes. (2017) Fertility preservation in women with CNS tumors. Expert Review of Anticancer Therapy 17:5, pages 439-445.
Read now
Read now
Matteo Lambertini, Maria Carolina Pescio, Giulia Viglietti, Oranite Goldrat, Lucia Del Mastro, Paola Anserini & Isabelle Demeestere. (2017) Methods of controlled ovarian stimulation for embryo/oocyte cryopreservation in breast cancer patients. Expert Review of Quality of Life in Cancer Care 2:1, pages 47-59.
Read now
Read now
Zeev Blumenfeld & Ayelet Evron. (2015) Preserving fertility when choosing chemotherapy regimens – the role of gonadotropin-releasing hormone agonists. Expert Opinion on Pharmacotherapy 16:7, pages 1009-1020.
Read now
Read now
Articles from other publishers (50)
Ioannis Boutas, Adamantia Kontogeorgi, Nektarios Koufopoulos, Dionysios T. Dimas, Kyparissia Sitara, Sophia N. Kalantaridou & Constantine Dimitrakakis. (2023) Breast Cancer and Fertility Preservation in Young Female Patients: A Systematic Review of the Literature. Clinics and Practice 13:6, pages 1413-1426.
Crossref
Crossref
Reiko Suzuki, Yuki Horage‐Okutsu, Tai Kawahara, Kentaro Nakamura, Eriko Shiraishi, Hideyuki Iwahata, Yuki Suzuki‐Takahashi, Yodo Sugishita, Seido Takae & Nao Suzuki. (2023) The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients. Journal of Obstetrics and Gynaecology Research 49:3, pages 973-979.
Crossref
Crossref
Sule Yildiz, Gamze Bildik, Can Benlioglu, Volkan Turan, Ece Dilege, Melis Ozel, Samuel Kim & Ozgur Oktem. (2023) Breast cancer treatment and ovarian function. Reproductive BioMedicine Online 46:2, pages 313-331.
Crossref
Crossref
Federico Ferrari, Martina Ratti, Anna Consoli, Filippo Alberto Ferrari, Enrico Sartori & Franco Odicino. 2023. Management of Infertility. Management of Infertility
363
386
.
Fukiko Kasuga-Yamashita, Tsuyoshi Baba, Sachiko Nagao, Yuya Fujibe, Miyuki Morishita, Yoshika Kuno, Tasuku Mariya, Hiroyuki Honnma, Toshiaki Endo, Tamotsu Kiya & Tsuyoshi Saito. (2022) Letrozole increases preantral follicle growth and decreases estradiol production without impairing follicle survival. Journal of Ovarian Research 15:1.
Crossref
Crossref
Oranite Goldrat, Manon De Cooman, Audrey Mailliez, Anne Delbaere, Emmanuelle D'Orazio, Isabelle Demeestere & Christine Decanter. (2022) Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study. European Journal of Cancer 174, pages 134-141.
Crossref
Crossref
Nathalie Rives, Blandine Courbière, Thierry Almont, Diana Kassab, Claire Berger, Michaël Grynberg, Aline Papaxanthos, Christine Decanter, Elisabeth Elefant, Nathalie Dhedin, Virginie Barraud-Lange, Marie-Christine Béranger, Charlotte Demoor-Goldschmidt, Nicollet Frédérique, Marianne Bergère, Lydie Gabrel, Marianne Duperray, Christine Vermel, Natalie Hoog-Labouret, Michèle Pibarot, Magali Provansal, Laurent Quéro, Hervé Lejeune, Charlotte Methorst, Jacqueline Saias, Jacqueline Véronique-Baudin, Sandrine Giscard d'Estaing, Fadila Farsi, Catherine Poirot & Éric Huyghe. (2022) What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. European Journal of Cancer 173, pages 146-166.
Crossref
Crossref
Eva M E Balkenende, Taghride Dahhan, Catharina C M Beerendonk, Kathrin Fleischer, Dominic Stoop, Annelies M E Bos, Cornelis B Lambalk, Roel Schats, Jesper M J Smeenk, Leonie A Louwé, Astrid E P Cantineau, Jan Peter de Bruin, Sabine C Linn, Fulco van der Veen, Madelon van Wely & Mariëtte Goddijn. (2022) Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols. Human Reproduction 37:8, pages 1786-1794.
Crossref
Crossref
Eleonora Porcu, Linda Cipriani, Maria Dirodi, Pierandrea De Iaco, Anna Myriam Perrone, Pier Luigi Zinzani, Mario Taffurelli, Claudio Zamagni, Patrizia Maria Ciotti, Leonardo Notarangelo, Nilla Calza & Giuseppe Damiano. (2022) Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation. Cancers 14:6, pages 1429.
Crossref
Crossref
Chih-Ning Chen, Lu-Te Chang, Chi-Huang Chen & Ka-Wai Tam. (2022) Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis. Reproductive BioMedicine Online 44:2, pages 357-369.
Crossref
Crossref
Yeon Hee Hong, Seul Ki Kim, Jung Ryeol Lee, Byung Chul Jee & Chang Suk Suh. (2022) Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation. Reproductive Medicine and Biology 21:1.
Crossref
Crossref
Vinita M. Alexander, Caitlin E. Martin, Allison P. Schelble, Alexandra B. Laufer, Angela Hardi, Laurie J. McKenzie, Heather S. Hipp, Jennifer F. Kawwass, Jessica B. Spencer & Emily S. Jungheim. (2021) Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts. Journal of Gynecology Obstetrics and Human Reproduction 50:8, pages 102080.
Crossref
Crossref
Joseph Letourneau, Flor Juarez-Hernandez, Kaitlyn Wald, Salustiano Ribeiro, Ange Wang, Charles E. McCulloch, Evelyn Mok-Lin, Milana Dolezal, A. Jo Chien, Marcelle I. Cedars & Mitchell Rosen. (2021) Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial. Journal of Assisted Reproduction and Genetics 38:9, pages 2455-2463.
Crossref
Crossref
Reda S. Hussein, Yulian Zhao & Zaraq Khan. (2021) Does type of cancer affect ovarian response in oncofertility patients?. Journal of Gynecology Obstetrics and Human Reproduction 50:6, pages 101944.
Crossref
Crossref
Molly B. Moravek, Rafael Confino, Angela K. Lawson, Kristin N. Smith, Ralph R. Kazer, Susan C. Klock, William J. Gradishar, Jacqueline S. Jeruss & Mary Ellen Pavone. (2021) Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation. Breast Cancer Research and Treatment 186:2, pages 429-437.
Crossref
Crossref
So Yun Park, Kyungah Jeong, Eun Hye Cho & Hye Won Chung. (2021) Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues. Clinical and Experimental Reproductive Medicine 48:1, pages 1-10.
Crossref
Crossref
Yael Shulman, Benny Almog, Yael Kalma, Yuval Fouks, Foad Azem & Yoni Cohen. (2021) Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients. Journal of Assisted Reproduction and Genetics 38:3, pages 743-750.
Crossref
Crossref
Laura C. Gemmell, Jason D. Wright & Paula C. Brady. (2020) Triple stimulation (TriStim) before bilateral oophorectomy in a young woman with ovarian cancer: a case report and review of the literature. Fertility Research and Practice 6:1.
Crossref
Crossref
Benedetta Bonardi, Claudia Massarotti, Marco Bruzzone, Oranite Goldrat, Giorgia Mangili, Paola Anserini, Stefano Spinaci, Luca Arecco, Lucia Del Mastro, Marcello Ceppi, Isabelle Demeestere & Matteo Lambertini. (2020) Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Mohd Faizal AhmadYodo SugishitaYuki Suzuki-TakahashiShino SawadaHideyuki IwahataEriko ShiraishiSeido TakaeYuki Horage-OkutsuNao Suzuki. (2020) Oncofertility Treatment Among Breast Cancer Women: A Paradigm Shift of Practice After a Decade of Service. Journal of Adolescent and Young Adult Oncology 9:4, pages 496-501.
Crossref
Crossref
Juliia E. Dobrokhotova & Kseniia V. Morozova. (2020) Opportunities for ovarian reserve preservation in the treatment of oncological diseases. Gynecology 21:6, pages 21-25.
Crossref
Crossref
Anna Marklund, Sandra Eloranta, Ida Wikander, Margareta Laczna Kitlinski, Mikael Lood, Elizabeth Nedstrand, Ann Thurin-Kjellberg, Pu Zhang, Jonas Bergh & Kenny A Rodriguez-Wallberg. (2020) Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer—a prospective nationwide Swedish multicenter study. Human Reproduction 35:4, pages 929-938.
Crossref
Crossref
Eleonora Porcu, Giulia Maria Cillo, Linda Cipriani, Federica Sacilotto, Leonardo Notarangelo, Giuseppe Damiano, Maria Dirodi & Ilaria Roncarati. (2019) Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer. Journal of Assisted Reproduction and Genetics 37:3, pages 709-715.
Crossref
Crossref
Dongming Liu, Jie Yan & Jie Qiao. (2019) Effects of malignancies on fertility preservation outcomes and relevant cryobiological advances. Science China Life Sciences 63:2, pages 217-227.
Crossref
Crossref
Monique Marguerie & Mohamed Bedaiwy. 2020. Textbook of Assisted Reproduction. Textbook of Assisted Reproduction
53
68
.
Ariane Germeyer. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
8
.
Matteo Lambertini & Fedro A. Peccatori. 2020. Breast Cancer in Young Women. Breast Cancer in Young Women
167
176
.
Orhan Bukulmez. 2020. Diminished Ovarian Reserve and Assisted Reproductive Technologies. Diminished Ovarian Reserve and Assisted Reproductive Technologies
157
174
.
M. E. (Elena) ter Welle-Butalid, I. J. H. (Ingeborg) Vriens, J. G. (Josien) Derhaag, E. M. (Edward) Leter, C. E. (Christine) de Die-Smulders, M. (Marjolein) Smidt, R. J. T. (Ron) van Golde & V. C. G. (Vivianne) Tjan-Heijnen. (2019) Counseling young women with early breast cancer on fertility preservation. Journal of Assisted Reproduction and Genetics 36:12, pages 2593-2604.
Crossref
Crossref
M. Salama, A. Anazodo & T.K. Woodruff. (2019) Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach. Annals of Oncology 30:11, pages 1760-1775.
Crossref
Crossref
Charlotte Sonigo, Nathalie Sermondade, Jéremy Calvo, Julie Benard, Christophe Sifer & Michaël Grynberg. (2019) Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 4, pages 100049.
Crossref
Crossref
Cristina Specchia, Annamaria Baggiani, Valentina Immediata, Camilla Ronchetti, Amalia Cesana, Antonella Smeraldi, Giulia Scaravelli & Paolo Emanuele Levi-Setti. (2019) Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center. Frontiers in Endocrinology 10.
Crossref
Crossref
L Bergandi, S Canosa, G Pittatore, F Silvagno, S Doublier, G Gennarelli, C Benedetto & A Revelli. (2019) Human recombinant FSH induces chemoresistance in human breast cancer cells via HIF-1α activation†. Biology of Reproduction 100:6, pages 1521-1535.
Crossref
Crossref
Rachael J. Rodgers. (2019) Fertility preservation in breast cancer patients. Minerva Ginecologica 71:3.
Crossref
Crossref
A. N. Schüring, T. Fehm, K. Behringer, M. Goeckenjan, P. Wimberger, M. Henes, J. Henes, M. F. Fey & M. von Wolff. (2017) Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Archives of Gynecology and Obstetrics 297:1, pages 241-255.
Crossref
Crossref
T. Dahhan, E.M.E. Balkenende, C.C.M. Beerendonk, K. Fleischer, D. Stoop, A.M.E. Bos, C.B. Lambalk, R. Schats, R.J.T. van Golde, I. Schipper, L.A. Louwé, A.E.P. Cantineau, J.M.J. Smeenk, J.P. de Bruin, N. Reddy, Y. Kopeika, F. van der Veen, M. van Wely, S.C. Linn & M. Goddijn. (2017) Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial. Contemporary Clinical Trials 61, pages 96-100.
Crossref
Crossref
Claudia Massarotti, Paola Scaruffi, Matteo Lambertini, Valentino Remorgida, Lucia Del Mastro & Paola Anserini. (2017) State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature. Cancer Treatment Reviews 57, pages 50-57.
Crossref
Crossref
Rachael J. Rodgers, Geoffrey D. Reid, Juliette Koch, Rebecca Deans, William L. Ledger, Michael Friedlander, Robert B. Gilchrist, Kirsty A. Walters & Jason A. Abbott. (2017) The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Human Reproduction 32:5, pages 1033-1045.
Crossref
Crossref
Hoon KimSeul Ki KimJung Ryeol LeeKyung Joo HwangChang Suk SuhSeok Hyun Kim. (2017) Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines. Clinical and Experimental Reproductive Medicine 44:4, pages 181.
Crossref
Crossref
Matteo Lambertini, Hatem A. AzimJrJr & Fedro A. Peccatori. 2017. Breast Cancer. Breast Cancer
729
737
.
Matteo Lambertini, Lucia Del Mastro, Maria C. Pescio, Claus Y. Andersen, Hatem A. AzimJr.Jr., Fedro A. Peccatori, Mauro Costa, Alberto Revelli, Francesca Salvagno, Alessandra Gennari, Filippo M. Ubaldi, Giovanni B. La Sala, Cristofaro De Stefano, W. Hamish Wallace, Ann H. Partridge & Paola Anserini. (2016) Cancer and fertility preservation: international recommendations from an expert meeting. BMC Medicine 14:1.
Crossref
Crossref
Keiichi Kato. (2016) Vitrification of embryos and oocytes for fertility preservation in cancer patients. Reproductive Medicine and Biology 15:4, pages 227-233.
Crossref
Crossref
Barbara Lawrenz, Nalini Mahajan & Human Mousavi Fatemi. (2016) The effects of cancer therapy on women's fertility: what do we know now?. Future Oncology 12:14, pages 1721-1729.
Crossref
Crossref
Matteo Lambertini & Lucia Del Mastro. (2016)
Fertility preservation in
BRCA
-mutated breast cancer patients
. Breast Cancer Management 5:2, pages 61-68.
Crossref
Crossref
Jovana Lekovich, Alexandre L. S. Lobel, Joshua D. Stewart, Nigel Pereira, Isaac Kligman & Zev Rosenwaks. (2016) Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies. Journal of Assisted Reproduction and Genetics 33:5, pages 657-662.
Crossref
Crossref
Hakan Cakmak & Mitchell P. Rosen. 2016. Gonadal Tissue Cryopreservation in Fertility Preservation. Gonadal Tissue Cryopreservation in Fertility Preservation
21
37
.
Pamela N. Munster. (2015) More Options for Fertility Preservation for Patients With Cancer. Journal of Clinical Oncology 33:22, pages 2413-2415.
Crossref
Crossref
M. Shapira, H. Raanani & D. Meirow. (2015) IVF for fertility preservation in breast cancer patients—efficacy and safety issues. Journal of Assisted Reproduction and Genetics 32:8, pages 1171-1178.
Crossref
Crossref
Ariel Revel & Jordana Hadassah Hyman. 2015. Principles and Practice of Controlled Ovarian Stimulation in ART. Principles and Practice of Controlled Ovarian Stimulation in ART
157
170
.
Dror Meirow, Hila Raanani, Ettie Maman, Shani Paluch-Shimon, Moran Shapira, Yoram Cohen, Irena Kuchuk, Ariel Hourvitz, Jacob Levron, Michal Mozer-Mendel, Masha Brengauz, Hana Biderman, Daphna Manela, Rephael Catane, Jehoshua Dor, Raoul Orvieto & Bella Kaufman. (2014) Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertility and Sterility 102:2, pages 488-495.e3.
Crossref
Crossref